277 related articles for article (PubMed ID: 14517172)
1. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory properties of statins.
Steffens S; Mach F
Semin Vasc Med; 2004 Nov; 4(4):417-22. PubMed ID: 15861323
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
4. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
5. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
[TBL] [Abstract][Full Text] [Related]
7. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
Suzuki J; Koga N; Kosuge H; Ogawa M; Haraguchi G; Maejima Y; Saiki H; Isobe M
Transplantation; 2007 Apr; 83(8):1093-7. PubMed ID: 17452900
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
Fleury S; Li J; Simeoni E; Fiorini E; von Segesser LK; Kappenberger L; Vassalli G
Gene Ther; 2006 Jul; 13(14):1104-9. PubMed ID: 16541117
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
[TBL] [Abstract][Full Text] [Related]
10. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
11. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
13. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
Vassalli G; Simeoni E; Li JP; Fleury S
Transplantation; 2006 Jan; 81(2):240-6. PubMed ID: 16436968
[TBL] [Abstract][Full Text] [Related]
15. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
Dechend R; Gieffers J; Dietz R; Joerres A; Rupp J; Luft FC; Maass M
Circulation; 2003 Jul; 108(3):261-5. PubMed ID: 12860900
[TBL] [Abstract][Full Text] [Related]
16. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells.
Ohkita M; Sugii M; Ka Y; Kitamura A; Mori T; Hayashi T; Takaoka M; Matsumura Y
Exp Biol Med (Maywood); 2006 Jun; 231(6):772-6. PubMed ID: 16740997
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
Han J; Parsons M; Zhou X; Nicholson AC; Gotto AM; Hajjar DP
Circulation; 2004 Nov; 110(22):3472-9. PubMed ID: 15557368
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
